PA
LKFT

Parallel Advisors’s Lakefront Biotherapeutics American Depositary Shares LKFT Stock Holding History

Parallel Advisors’s Portfolio LKFT Stock Details LKFT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.35K Buy
145
+42
+41% +$1.19K ﹤0.01% 3269
2026
Q1 		$3.09K Hold
103
– – ﹤0.01% 3216
2025
Q4 		$3.37K Sell
103
-50
-33% -$1.61K ﹤0.01% 2977
2025
Q3 		$5.3K Buy
153
+50
+49% +$1.6K ﹤0.01% 2753
2025
Q2 		$2.88K Sell
103
-153
-60% -$4.1K ﹤0.01% 2931
2025
Q1 		$6.43K Sell
256
-861
-77% -$21.8K ﹤0.01% 2594
2024
Q4 		$30.7K Sell
1,117
-380
-25% -$10.6K ﹤0.01% 1927
2024
Q3 		$43.1K Buy
1,497
+660
+79% +$18K ﹤0.01% 1712
2024
Q2 		$20.7K Buy
837
+748
+840% +$21.2K ﹤0.01% 1966
2024
Q1 		$2.87K Sell
89
-311
-78% -$11.6K ﹤0.01% 2710
2023
Q4 		$16.3K Buy
+400
New +$14.7K ﹤0.01% 2069
2023
Q3 		– Sell
-9
Closed -$366 – 3420
2023
Q2 		$366 Buy
+9
New +$367 ﹤0.01% 3163
2022
Q4 		– Sell
-35
Closed -$1K – 3421
2022
Q3 		$1K Sell
35
-31
-47% -$1.59K ﹤0.01% 2909
2022
Q2 		$4K Hold
66
– – ﹤0.01% 2345
2022
Q1 		$4K Buy
66
+18
+38% +$1.1K ﹤0.01% 2367
2021
Q4 		$3K Buy
48
+32
+200% +$1.67K ﹤0.01% 2571
2021
Q3 		$1K Buy
16
+1
+7% +$59 ﹤0.01% 2860
2021
Q2 		$1K Buy
15
+6
+67% +$458 ﹤0.01% 2735
2021
Q1 		$1K Sell
9
-96
-91% -$8.84K ﹤0.01% 2621
2020
Q4 		$10K Buy
105
+94
+855% +$11.5K ﹤0.01% 1780
2020
Q3 		$2K Buy
11
+5
+83% +$834 ﹤0.01% 2299
2020
Q2 		$1K Hold
6
– – ﹤0.01% 2318
2020
Q1 		$1K Buy
+6
New +$1.29K ﹤0.01% 2271
2018
Q4 		– Sell
-20
Closed -$2K – 2173
2018
Q3 		$2K Hold
20
– – ﹤0.01% 2005
2018
Q2 		$1K Buy
+20
New +$1.94K ﹤0.01% 1972

Other funds holding LKFT

GS
Gilead Sciences Foster City, California $1.65B AUM 166.99% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AA
ALPS Advisors Denver, Colorado $21.3B AUM 23.41% 1-Year Est. Return
MAM
Monaco Asset Management Monaco $1.26B AUM 60.23% 1-Year Est. Return
DO
denkapparat Operations Berlin, Germany $306M AUM 40.46% 1-Year Est. Return
QCM
QRG Capital Management Chicago, Illinois $12.1B AUM 44.98% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $79.5B AUM 27.1% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.67B AUM 89% 1-Year Est. Return

Parallel Advisors's LKFT Position: Q2 2026 in Review

Parallel Advisors increased its Lakefront Biotherapeutics American Depositary Shares (LKFT) stake by 41% in Q2 2026, buying an estimated $1.19K and bringing the position to 145 shares worth $4.35K. The position accounts for ﹤0.01% of the portfolio, ranked #3269.

Parallel Advisors first reported a position in LKFT in Q2 2018 and has held it in 25 quarters since. The position peaked at $43.1K in Q3 2024. 24 funds tracked by Wall St. Rank hold LKFT as of Q2 2026.

  • Parallel Advisors held 145 shares of Lakefront Biotherapeutics American Depositary Shares worth $4.35K as of Q2 2026.
  • Parallel Advisors bought 42 Lakefront Biotherapeutics American Depositary Shares shares in Q2 2026, an estimated $1.19K.
  • Lakefront Biotherapeutics American Depositary Shares made up ﹤0.01% of Parallel Advisors's portfolio in Q2 2026, its #3269 holding.
  • Parallel Advisors first reported a position in Lakefront Biotherapeutics American Depositary Shares in Q2 2018 and has held it in 25 quarters since.
  • Parallel Advisors's Lakefront Biotherapeutics American Depositary Shares position peaked at $43.1K in Q3 2024.
  • 24 funds tracked by Wall St. Rank held Lakefront Biotherapeutics American Depositary Shares as of Q2 2026.

Based on Parallel Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.